HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of gamma-butyrobetaine on fatty liver in juvenile visceral steatosis mice.

Abstract
We pharmacokinetically examined the effect of gamma-butyrobetaine, a precursor of L-carnitine, on the change of fatty acid metabolism in juvenile visceral steatosis (JVS) mice, which have systemic L-carnitine deficiency due to lack of L-carnitine transporter activity. The concentrations of total free fatty acid (FFA), palmitic acid and stearic acid in the liver of JVS mice were significantly higher than those in wild-type mice. After intravenous administration of gamma-butyrobetaine (50 mg kg(-1)), the concentration of L-carnitine in the plasma of JVS mice reached about twice that of the control level and levels in the brain, liver and kidney were also significantly increased, whereas those in wild-type mice hardly changed. Although the plasma concentrations of FFA in both types of mice were unchanged after administration of gamma-butyrobetaine, the concentrations of palmitic acid and stearic acid were significantly decreased. In particular, the liver concentration of FFA in JVS mice was decreased to the wild-type control level, accompanied by significant decreases in long-chain fatty acids, palmitic acid and stearic acid, whereas those in wild-type mice were not changed. These results suggest that gamma-butyrobetaine can be taken up into organs, including the liver, of JVS mice, and transformed to L-carnitine. Consequently, administration of gamma-butyrobetaine may be more useful than that of L-carnitine itself for treatment of primary deficiency of carnitine due to a functional defect of the carnitine transporter.
AuthorsY Higashi, K Yokogawa, N Takeuchi, I Tamai, M Nomura, N Hashimoto, J I Hayakawa, K I Miyamoto, A Tsuji
JournalThe Journal of pharmacy and pharmacology (J Pharm Pharmacol) Vol. 53 Issue 4 Pg. 527-33 (Apr 2001) ISSN: 0022-3573 [Print] England
PMID11341370 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carrier Proteins
  • Fatty Acids
  • Organic Cation Transport Proteins
  • Slc22a5 protein, mouse
  • Solute Carrier Family 22 Member 5
  • Betaine
  • gamma-butyrobetaine
  • Carnitine
Topics
  • Animals
  • Betaine (analogs & derivatives, metabolism, pharmacology)
  • Carnitine (deficiency)
  • Carrier Proteins (drug effects, pharmacology)
  • Disease Models, Animal
  • Fatty Acids (metabolism)
  • Infusions, Intravenous
  • Liver (chemistry, physiology)
  • Mice
  • Organic Cation Transport Proteins
  • Solute Carrier Family 22 Member 5

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: